Pyrido[4,3-B]indoles and methods of use
US8927571B2 · kind B2 · utility
26Cited by
16References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 8, 2013 |
| Grant date | Jan 6, 2015 |
| Priority date | — |
| Expiry date | Mar 8, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
New heterocyclic compounds that may be used to modulate a histamine receptor in an individual are described. Pyrido[4,3-b]indoles are described, as are pharmaceutical compositions comprising the compounds and methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.